Hemerion Therapeutics logo

Hemerion Therapeutics jobs and careers

France

About Hemerion Therapeutics

Hemerion is a clinical stage HealthTech company. Its first breakthrough technology jointly designed with University of Lille, Inserm and University Hospital of Lille, addresses brain cancer and aims to help patients in their fight against glioblastoma. Hemerion results of over 10 years of leading academic and clinical researches on innovative approaches to treat Glioblastoma. Today, Hemerion owns a unique and disruptive technology, already evaluated in frontline approach to treat patients harboring brain cancer.

Founded
2020
Employees
11 to 50
Total funding
$2M
Headquarters
France

Leadership

The top of Hemerion Therapeutics's org chart, with how many people report into each leader.

MVPhoto of Maximilien Vermandel

Maximilien Vermandel

Chief Executive Officer